In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry (Pharmaceutical, Cosmetics), Region-Global Forecast to 2024

Table of Contents

1.... INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.3            MARKET SCOPE
1.3.1               MARKETS COVERED.. 23
1.3.2               YEARS CONSIDERED FOR THE STUDY
1.4            CURRENCY
1.5            STAKEHOLDERS
1.6            LIMITATIONS

2.... RESEARCH METHODOLOGY

2.1            RESEARCH APPROACH
2.1.1               SECONDARY RESEARCH
2.1.1.1             KEY DATA FROM SECONDARY SOURCES
2.1.2               PRIMARY RESEARCH.. 28
2.1.2.1             KEY DATA FROM PRIMARY SOURCES
2.1.2.2             BREAKDOWN OF PRIMARIES
2.2            MARKET SIZE ESTIMATION
2.3            DATA TRIANGULATION APPROACH
2.4            MARKET SHARE ESTIMATION
2.5            ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1            IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW
4.2            ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD
4.3            IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4            IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (2017–2024)
4.5            IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS

5.... MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
5.2.1               MARKET DRIVERS
5.2.1.1             OPPOSITION TO ANIMAL TESTING
5.2.1.2             TECHNOLOGICAL ADVANCEMENTS
5.2.1.3             R&D ON EARLY-STAGE TOXICITY DETECTION

5.2.2               MARKET RESTRAINTS. 47
5.2.2.1             RELUCTANCE OF REGULATORY AUTHORITIES TO CONSIDER ALTERNATIVE METHODS FOR PROVING SAFETY AND EFFICACY
5.2.2.2             FAILURE TO ESTABLISH THE INTRICACIES OF IN VIVO CONDITIONS
5.2.2.3             LACK OF IN VITRO MODELS TO STUDY COMPLEX ENDPOINTS
5.2.3               MARKET OPPORTUNITIES
5.2.3.1             INCREASING FOCUS ON DRUG DISCOVERY AND PERSONALIZED MEDICINE USING IN VITRO METHODS
5.2.3.2             INCREASING NUMBER OF TOXICOLOGY DATABASES
5.2.4               MARKET CHALLENGES. 50
5.2.4.1             DEARTH OF SKILLED PROFESSIONALS

6.... INDUSTRY INSIGHTS

6.1            INTRODUCTION
6.2            INDUSTRY TRENDS
6.2.1               INCREASING FOCUS ON PREDICTIVE TOXICOLOGY
6.3            SUPPLY CHAIN ANALYSIS
6.4            REGULATORY COMMITTEE ACTIVITIES
6.4.1               MAJOR STAKEHOLDERS
6.4.2               KEY INFLUENCERS. 53

7.... IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE

7.1            INTRODUCTION
7.2            CONSUMABLES
7.2.1               CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
7.3            ASSAYS
7.3.1               BACTERIAL TOXICITY ASSAYS
7.3.1.1             BACTERIAL ASSAYS DOMINATE THE MARKET AS THEY ARE THE MOST WIDELY ADOPTED ASSAY TYPE ACROSS INDUSTRIES
7.3.2               ENZYME TOXICITY ASSAYS
7.3.2.1             ENZYME TOXICITY ASSAYS ARE INCREASINGLY USED FOR ENDOCRINE-DISRUPTING STUDIES—A KEY FACTOR DRIVING MARKET GROWTH
7.3.3               CELL-BASED ELISA & WESTERN BLOTS
7.3.3.1             CELL-BASED ASSAYS ARE COST-EFFECTIVE, OWING TO WHICH THEY ARE WITNESSING INCREASING ADOPTION IN DRUG DISCOVERY
7.3.4               RECEPTOR-BINDING ASSAYS
7.3.4.1             RECEPTOR-BINDING ASSAYS ARE WELL-SUITED FOR HIGH-THROUGHPUT FORMATS, A KEY FACTOR DRIVING THE ADOPTION OF THESE PRODUCTS
7.3.5               TISSUE CULTURE ASSAYS
7.3.5.1             TISSUE CULTURE ASSAYS OFFER THE ADVANTAGE OF MIMICKING IN VIVO TISSUE ARCHITECTURE
7.3.6               OTHER ASSAYS

7.4            EQUIPMENT
7.4.1               FULLY AUTOMATED EQUIPMENT IS WITNESSING GROWING ADOPTION IN RESEARCH
7.5            SOFTWARE
7.5.1               SOFTWARE TOOLS ARE VITAL IN REDUCING ANALYSIS TIMES AND MANAGING LARGE AMOUNTS OF DATA GENERATED IN OPERATIONS
7.6            SERVICES
7.6.1               LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS

8.... IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST

8.1            INTRODUCTION
8.2            ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
8.2.1               ADME TESTING TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
8.3            SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
8.3.1               SKIN IRRITATION, CORROSION, AND SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN THE COSMETICS INDUSTRY
8.4            GENOTOXICITY TESTING
8.4.1               MORE GENOTOXICITY TESTS ARE REVIEWED AND VALIDATED BY REGULATORY AUTHORITIES THAN ANY OTHER ENDPOINT—A KEY DRIVER FOR MARKET GROWTH
8.5            CYTOTOXICITY TESTING
8.5.1               RISING NEED FOR BIOSAFETY IS LARGELY CONTRIBUTING TO THE GROWTH OF THE CYTOTOXICITY TESTING MARKET
8.6            OCULAR TOXICITY TESTING
8.6.1               IN VITRO AND EX VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING
8.7            ORGAN TOXICITY TESTING
8.7.1               HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY
8.8            PHOTOTOXICITY TESTING
8.8.1               VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE THE PHOTOSAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS
8.9            DERMAL TOXICITY TESTING
8.9.1               IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN THE COMING YEARS
8.10          OTHER TOXICITY ENDPOINTS & TESTS

9.... IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY

9.1            INTRODUCTION
9.2            CELL CULTURE TECHNOLOGIES
9.2.1               CELL- & TISSUE-BASED TECHNOLOGIES ARE THE MOST WIDELY ADOPTED IN IN VITRO TESTING

9.3            HIGH-THROUGHPUT TECHNOLOGIES
9.3.1               INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IS DRIVING MARKET GROWTH
9.4            TOXICOGENOMICS
9.4.1               IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ARE ENHANCING THE STUDY OF GENE & PROTEIN ACTIVITY DURING TOXICITY ANALYSIS

10.. IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY

10.1          INTRODUCTION
10.2          PHARMACEUTICALS & BIOPHARMACEUTICALS
10.2.1             DRUG ATTRITION RATE IS LEADING TO THE HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN THE EARLY STAGES OF DRUG DEVELOPMENT
10.3          COSMETICS & HOUSEHOLD PRODUCTS
10.3.1             BAN ON ANIMAL TESTING IS INCREASING THE ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING
10.4          FOOD
10.4.1             INCREASING FOCUS ON FOOD SAFETY IS DRIVING MARKET GROWTH
10.5          CHEMICALS
10.5.1             INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICAL TESTING IS PROPELLING THE MARKET

11.. IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD

11.1          INTRODUCTION
11.2          CELLULAR ASSAYS
11.2.1             DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS
11.3          BIOCHEMICAL ASSAYS
11.3.1             BIOCHEMICAL ASSAYS FIND WIDER APPLICATION IN THE PHARMACEUTICAL INDUSTRY AS COMPARED TO THE CHEMICAL AND FOOD INDUSTRIES
11.4          IN SILICO MODELS
11.4.1             IN SILICO MODELS ARE EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
11.5          EX VIVO MODELS
11.5.1             EX VIVO MODELS ARE WIDELY USED IN SKIN & EYE TOXICITY TESTING IN THE COSMETIC INDUSTRY

12.. IN VITRO TOXICOLOGY TESTING MARKET, BY REGION

12.1          INTRODUCTION
12.2          EUROPE
12.2.1             GERMANY
12.2.1.1           GERMANY HOLDS THE LARGEST SHARE OF THE EUROPEAN MARKET
12.2.2             UK
12.2.2.1           RISING AWARENESS, GROWING R&D, AND INCREASING COLLABORATIONS ARE KEY INDICATORS OF MARKET GROWTH IN THE UK

12.2.3             FRANCE
12.2.3.1           RESEARCH INITIATIVES SUPPORTED BY THE GOVERNMENT ARE AIDING MARKET GROWTH IN FRANCE
12.2.4             ITALY
12.2.4.1           GROWTH IN THIS MARKET IS MAINLY DRIVEN BY THE INCREASING LIFE SCIENCE R&D
12.2.5             SPAIN
12.2.5.1           SPAIN’S GROWING CHEMICAL INDUSTRY IS A MAJOR FACTOR SUPPORTING THE IN VITRO TOXICOLOGY TESTING MARKET IN THE COUNTRY
12.2.6             REST OF EUROPE
12.3          NORTH AMERICA
12.3.1             US
12.3.1.1           THE US DOMINATES THE NORTH AMERICAN IN VITRO TOXICOLOGY TESTING MARKET DUE TO A GROWING FOCUS ON BIOMARKER DISCOVERY AND RESEARCH IN THE FIELD OF STRUCTURE-BASED DRUG DESIGN
12.3.2             CANADA
12.3.2.1           STRONG SUPPORT FOR R&D AND FOCUS ON DEVELOPING NEW THERAPIES WILL SUPPORT MARKET GROWTH IN CANADA
12.4          ASIA PACIFIC
12.4.1             CHINA
12.4.1.1           INCREASING INTERNATIONAL PRESSURE TO BAN ANIMAL TESTING METHODS WILL PROPEL MARKET GROWTH IN THE COMING YEARS
12.4.2             JAPAN
12.4.2.1           USE OF ARTIFICIAL SKIN PATCHES AND PLATES OF CULTURED HUMAN CELLS HAS INCREASED IN JAPAN
12.4.3             INDIA
12.4.3.1           GROWING CRAMS INDUSTRY AND THE BAN ON THE USE OF ANIMALS IN COSMETICS AND UNIVERSITIES ARE LIKELY TO PROPEL MARKET GROWTH
12.4.4             REST OF ASIA PACIFIC
12.5          LATIN AMERICA
12.5.1             LOW COST OF DRUG TRIALS HAVE MADE LATIN AMERICA A POPULAR OUTSOURCING MARKET
12.6          MIDDLE EAST & AFRICA
12.6.1             INCREASING R&D INVESTMENTS AND FOCUS ON THE DEVELOPMENT OF NEW DRUGS ARE CONTRIBUTING TO MARKET GROWTH

13.. COMPETITIVE LANDSCAPE

13.1          OVERVIEW
13.2          MARKET SHARE ANALYSIS
13.3          COMPETITIVE LEADERSHIP MAPPING
13.3.1             VISIONARY LEADERS. 177
13.3.2             INNOVATORS
13.3.3             DYNAMIC DIFFERENTIATORS
13.3.4             EMERGING COMPANIES

13.4          COMPETITIVE SITUATION AND TRENDS
13.4.1             PRODUCT & SERVICE LAUNCHES
13.4.2             EXPANSIONS
13.4.3             ACQUISITIONS
13.4.4             OTHER STRATEGIES. 182

14.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW)*
14.1          THERMO FISHER SCIENTIFIC, INC.
14.2          MERCK KGAA
14.3          EUROFINS SCIENTIFIC SE
14.4          GE HEALTHCARE
14.5          COVANCE, INC.
14.6          CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
14.7          SGS S.A.
14.8          BIO-RAD LABORATORIES, INC.
14.9          QIAGEN N.V.
14.10       CYPROTEX PLC
14.11       PROMEGA CORPORATION
14.12       CATALENT, INC.
14.13       GENTRONIX LIMITED
14.14       MB RESEARCH LABORATORIES
14.15       BIOIVT
14.16       CREATIVE BIOLABS
14.17       GVK BIOSCIENCES PRIVATE LIMITED
14.18       SHANGHAI MEDICILON INC.
14.19       CREATIVE BIOARRAY
14.20       INSPHERO
*BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

15.. APPENDIX

LIST OF TABLES

TABLE 1               IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 2               IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 3               IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 4               IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 5               BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 6               ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7               CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 8               RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9               TISSUE CULTURE ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10             OTHER ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11             IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 12             IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 13             IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 14             IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST,
2017–2024 (USD MILLION)
TABLE 15             ADME TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16             SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17             GENOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 18             CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 19             OCULAR TOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20             ORGAN TOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21             PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22             DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 23             OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 24             IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 25             IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 26             IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 27             IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 28             IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 29             PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 30             COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 31             TYPES OF TOXICOLOGICAL TESTS IN THE FOOD INDUSTRY
TABLE 32             FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 33             CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 34             IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 35             IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 36             IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 37             IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38             IN VITRO TOXICOLOGY TESTING MARKET FOR EX VIVO MODELS,
BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 39             IN VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 40             EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 41             EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 42             EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 43             EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 44             EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 45             EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 46             EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 47             GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT &
SERVICE, 2017–2024 (USD MILLION)
TABLE 48             GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 49             GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 50             GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 51             GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 52             GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 53             UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 54             UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 55             UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 56             UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 57             UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 58             UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 59             FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 60             FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 61             FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 62             FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 63             FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 64             FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 65             ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 66             ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 67             ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 68             ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 69             ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 70             ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 71             SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 72             SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 73             SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT &
TEST, 2017–2024 (USD MILLION)
TABLE 74             SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 75             SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 76             SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 77             ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 78             ROE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 79             ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 80             ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 81             ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 82             ROE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 83             NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 84             NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 85             NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 86             NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 87             NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 88             NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 89             NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 90             US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 91             US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 92             US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 93             US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 94             US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 95             US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 96             CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 97             CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 98             CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 99             CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 100          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 101          CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 102          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 103          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 104          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 105          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 106          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 107          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 108          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 109          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 110          CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 111          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 112          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 113          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 114          CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 115          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 116          JAPAN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 117          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 118          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 119          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 120          JAPAN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 121          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 122          INDIA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 123          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 124          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 125          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 126          INDIA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 127          ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 128          ROAPAC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 129          ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 130          ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION)
TABLE 131          ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 132          ROAPAC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 133          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 134          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 135          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 136          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 137          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017–2024 (USD MILLION)
TABLE 138          LATIN AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017–2024 (USD MILLION)
TABLE 139          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 140          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET,
BY TYPE, 2017–2024 (USD MILLION)
TABLE 141          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017–2024 (USD MILLION)
TABLE 142          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 143          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017–2024 (USD MILLION)
TABLE 144          MIDDLE EAST & AFRICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017–2024 (USD MILLION)
TABLE 145          PRODUCT & SERVICE LAUNCHES, 2017–2019
TABLE 146          EXPANSIONS, 2017–2019
TABLE 147          ACQUISITIONS, 2017–2019
TABLE 148          OTHER STRATEGIES, 2017–2019

LIST OF FIGURES

FIGURE 1             IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 2             RESEARCH DESIGN
FIGURE 3             BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION
FIGURE 4             MARKET SIZE APPROACH
FIGURE 5             BOTTOM-UP APPROACH
FIGURE 6             DATA TRIANGULATION METHODOLOGY
FIGURE 7             IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2019 VS. 2024 (USD MILLION)
FIGURE 8             IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST,
2019 VS. 2024 (USD MILLION)
FIGURE 9             IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2019 VS. 2024 (USD MILLION)
FIGURE 10          IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2019 VS. 2024 (USD MILLION)
FIGURE 11          IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2019 VS. 2024 (USD MILLION)
FIGURE 12          GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 13          OPPOSITION TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING MARKET GROWTH
FIGURE 14          CELLULAR ASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC IN VITRO TOXICOLOGY TESTING MARKET IN 2018
FIGURE 15          CHINA SHOWS THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD
FIGURE 16          EUROPE WILL CONTINUE TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET IN 2024   42
FIGURE 17          DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD
FIGURE 18          IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 19          SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET
FIGURE 20          CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
FIGURE 21          ORGAN TOXICITY TESTING TO REGISTER THE HIGHEST GROWTH IN THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD
FIGURE 22          TOXICOGENOMICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 23          PHARMACEUTICALS & BIOPHARMACEUTICALS TO COMMAND THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD
FIGURE 24          IN SILICO MODELS TO REGISTER THE HIGHEST GROWTH DURING
THE FORECAST PERIOD
FIGURE 25          IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT (2018)
FIGURE 26          EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 27          TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2017)
FIGURE 28          NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 29          ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT
FIGURE 30          KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM
2017 TO AUGUST 2019
FIGURE 31          IN VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2018
FIGURE 32          IN VITRO TOXICOLOGY TESTING MARKET: COMPETITIVE LEADERSHIP
MAPPING (2018)
FIGURE 33          THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2018)
FIGURE 34          MERCK KGAA: COMPANY SNAPSHOT (2018)
FIGURE 35          EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2018)
FIGURE 36          GE HEALTHCARE: COMPANY SNAPSHOT (2018)
FIGURE 37          LABORATORY CORPORATION OF AMERICA HOLDINGS:
COMPANY SNAPSHOT (2018)
FIGURE 38          CHARLES RIVER LABORATORIES INTERNATIONAL, INC.:
COMPANY SNAPSHOT (2018)
FIGURE 39          SGS S.A.: COMPANY SNAPSHOT (2018)
FIGURE 40          BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2018)
FIGURE 41          QIAGEN N.V.: COMPANY SNAPSHOT (2018)
FIGURE 42          EVOTEC AG: COMPANY SNAPSHOT (2018)
FIGURE 43          CATALENT, INC.: COMPANY SNAPSHOT (2018)

当レポートのプレスリリースは発行されておりません。